Showing results (541-550 of 566) with videos related to

Sort By:
Pageof 57
Pain|September 12, 2021
Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendationsBethea A Kleykamp, Robert H Dworkin, Dennis C Turk, et al.
Annals of the Rheumatic Diseases|February 5, 2011
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trialsDavid T Felson, Josef S Smolen, George Wells, et al.
Arthritis and Rheumatism|February 5, 2011
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trialsDavid T Felson, Josef S Smolen, George Wells, et al.
Arthritis and Rheumatism|September 29, 2004
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosusMichelle A Petri, Philip J Mease, Joan T Merrill, et al.
Pain|April 9, 2016
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendationsAnn M Taylor, Kristine Phillips, Kushang V Patel, et al.
Thorax|December 26, 2013
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trialsLesley Ann Saketkoo, Shikha Mittoo, Dörte Huscher, et al.
Nature Genetics|March 11, 2008
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutVeronique Vitart, Igor Rudan, Caroline Hayward, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceJosef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, et al.
The Journal of Clinical Investigation|December 16, 2014
Defective removal of ribonucleotides from DNA promotes systemic autoimmunityClaudia Günther, Barbara Kind, Martin A M Reijns, et al.
Respiration; International Review of Thoracic Diseases|February 5, 2026
Sex-specific phenotypes and outcomes in non‑IPF interstitial lung disease: results from the INSIGHTS‑ILD registryDirk Koschel, Francesco Bonella, Andreas Günther, et al.
Pageof 57